GIFT4 fusokine converts leukemic B cells into immune helper cells

about

Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteins.Stable incorporation of GM-CSF into dissolvable microneedle patch improves skin vaccination against influenza.

P2860

Q47277628-B3E7B0C3-A4FF-4F95-A091-ADDF599961AB Q50533261-67311494-A940-4CDE-91E1-0831ABB9F6BF

P2860

GIFT4 fusokine converts leukemic B cells into immune helper cells

Item

http://www.wikidata.org/entity/Q36842259

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

GIFT4 fusokine converts leukemic B cells into immune helper cells

@en

type

Item

label

GIFT4 fusokine converts leukemic B cells into immune helper cells

@en

prefLabel

GIFT4 fusokine converts leukemic B cells into immune helper cells

@en

P1476

GIFT4 fusokine converts leukemic B cells into immune helper cells

@en

P2093

Andrea Pennati

http://www.w3.org/2001/XMLSchema#string

Christopher R Flowers

http://www.w3.org/2001/XMLSchema#string

Jacques Galipeau

http://www.w3.org/2001/XMLSchema#string

Jian Hui Wu

http://www.w3.org/2001/XMLSchema#string

Jiusheng Deng

http://www.w3.org/2001/XMLSchema#string

Jonathon B Cohen

http://www.w3.org/2001/XMLSchema#string

Spencer Ng

http://www.w3.org/2001/XMLSchema#string

Yuanqiang Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.

CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia.

Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.

Gene immunotherapy of chronic lymphocytic leukemia: a phase I study of intranodally injected adenovirus expressing a chimeric CD154 molecule.

Modeling tumor-host interactions of chronic lymphocytic leukemia in xenografted mice to study tumor biology and evaluate targeted therapy

P2888

s12967-016-0865-1

P304

106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12967-016-0865-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1009397561

http://www.w3.org/2001/XMLSchema#string

P698

27118475

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

4847253

http://www.w3.org/2001/XMLSchema#string

GIFT4 fusokine converts leukemic B cells into immune helper cells

about

P2860

P2860

GIFT4 fusokine converts leukemic B cells into immune helper cells

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P932